Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.36%
1,040.69
-3.71
-0.36%
1,044.401,041.751,048.311,037.77
SIXC
Communications
SIXC
Communications
SIXC
-1.59%
560.36
-9.05
-1.59%
569.41569.41569.41558.54
SIXE
Energy
SIXE
Energy
SIXE
+1.71%
1,317.69
+22.18
+1.71%
1,295.511,294.951,321.871,289.74
SIXI
Industrials
SIXI
Industrials
SIXI
-1.27%
1,606.91
-20.60
-1.27%
1,627.511,623.211,627.281,603.21
SIXM
Financials
SIXM
Financials
SIXM
-2.49%
590.28
-15.10
-2.49%
605.38603.79603.79588.51
SIXR
Staples
SIXR
Staples
SIXR
+0.79%
827.98
+6.50
+0.79%
821.48822.07833.11819.99
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.68%
197.04
-1.35
-0.68%
198.39198.39199.10196.67
SIXT
Technology
SIXT
Technology
SIXT
-1.92%
2,618.20
-51.38
-1.92%
2,669.582,654.812,660.502,611.26
SIXU
Utilities
SIXU
Utilities
SIXU
+0.61%
924.66
+5.61
+0.61%
919.05920.79933.78918.70
SIXV
Health care
SIXV
Health care
SIXV
-1.71%
1,449.59
-25.17
-1.71%
1,474.761,475.771,475.771,447.42
SIXY
Discretionary
SIXY
Discretionary
SIXY
-2.87%
2,136.89
-63.11
-2.87%
2,200.002,191.332,191.332,132.17
BBOT:NASDAQ
BridgeBio Oncology Therapeutics Inc
$8.88
-3.79%
(-0.35) 1D
$8.82
-0.68% (-0.060)
After hours
Closed: Mar 27, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBOT...
Open
$9.23
High
$9.36
Low
$8.86
Mkt. cap
710.69M
Avg. vol.
214.51K
Volume
143.75K
P/E ratio
44.49
52-wk high
$14.87
52-wk low
$8.50
EPS
$0.20
Shares outstanding
80.03M
No. of employees
92
News stories
From sources across the web
About BridgeBio Oncology Therapeutics Inc
CEO-
Employees92
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitebbotx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.64M
27.44M
35.05M
38.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.50M
2.66M
14.13M
5.33M
Operating expense
23.14M
30.09M
49.18M
43.41M
Total operating expenses
23.14M
30.09M
49.18M
43.41M
Operating income
-23.14M
-30.09M
-49.18M
-43.41M
Other non operating income
-727.00K
-8.00K
980.00K
187.00K
EBT including unusual items
-22.06M
-28.44M
-44.76M
-38.80M
EBT excluding unusual items
-22.06M
-28.44M
-44.76M
-38.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22.06M
-28.44M
-44.76M
-38.80M
Net profit margin
-
-
-
-
Earnings per share
-
-
-1.03
-0.49
Interest and investment income
1.81M
1.67M
3.44M
4.42M
Interest expense
-
-
-
-
Net interest expenses
1.81M
1.67M
3.44M
4.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.08M
-30.02M
-49.11M
-43.32M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more